Prognia
Drug Database
🇪🇺EU · EMARefusedATC: H05AA

Eladynos(abaloparatide)

Osteoporosis

Marketing Authorisation Holder: Radius Health Ireland Ltd

INN: abaloparatide

Indication

Treatment of osteoporosis.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Eladynos — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.